Published: June 19th 2024 | Updated: June 24th 2024
Utilizing Biomarkers to Develop First-in-Class Antibody Drug Conjugates to Treat Advanced Solid Tumors
Published: December 9th 2024 | Updated: December 11th 2024
Yescarta Demonstrates Promise in Treating Relapsed/Refractory Large B-Cell Lymphoma
Published: December 9th 2024 | Updated: December 11th 2024
Pharma Pulse 12/9/24: Technology's Role in Achieving Greater DE&I, Out-of-Pocket MS Med Costs Rise, Others Drop & more
Published: December 6th 2024 | Updated: December 11th 2024
The Launch of SPIMA Therapeutics
Published: November 20th 2024 | Updated: December 11th 2024
The Influence of PD-1 Inhibitor Label Restrictions on Future Studies
Published: November 5th 2024 | Updated: December 11th 2024
FDA Challenges to Broad Label Laws for PD-1 Inhibitors